Liposome Characterization

Importance of the Topic

Liposome size distribution is a critical quality attribute in pharmaceutical and cosmetic applications, influencing drug delivery efficiency, stability, and bioavailability. Accurate measurement of vesicle dimensions ensures consistent performance in clinical and industrial settings.

Objectives and Study Overview

This application note evaluates the performance of a cross-flow field-flow fractionation (FFF) system combined with multi-angle light scattering (MALS) for absolute determination of liposome sizes in pharmaceutical formulations, several of which are in Phase II clinical trials.

Methodology and Instrumentation

• Field-Flow Fractionation (FFF): Separation without a stationary phase to prevent artifacts typical of size-exclusion chromatography.
• DAWN Multi-Angle Light Scattering (MALS): An 18-angle detector measuring scattered light to derive root mean square (RMS) radius directly from angular variations.

Main Results and Discussion

When eluted through FFF, smaller liposomes appeared first, in contrast to gel permeation chromatography behaviour. The RMS radius versus elution volume profile revealed a dominant peak around 95 nm, with a broader distribution extending up to approximately 180 nm. Differential weight fraction analysis confirmed the main size mode and highlighted sample polydispersity. The overlay of the 90° scattering signal with the RMS radius profile demonstrated excellent correlation between fractionation and size measurement.

Benefits and Practical Applications

• Absolute size determination without reliance on calibration standards or mathematical deconvolution.
• High resolution of complex, polydisperse samples, enabling detailed distribution profiles.
• Rapid and artifact-free analysis suitable for routine quality control in pharmaceutical manufacturing.

Future Trends and Opportunities

Emerging developments may include integration of FFF-MALS with complementary detectors (e.g., dynamic light scattering, fluorescence), miniaturized platforms for high-throughput screening, and real-time process monitoring. These innovations could extend applications to personalized medicine, lipid nanoparticle vaccines, and advanced biopharmaceutical characterization.

Conclusion

The combined FFF-MALS approach provides a robust, accurate, and efficient method for liposome size characterization, addressing limitations of traditional techniques and supporting stringent pharmaceutical requirements.

Reference

• Wyatt Technology Corporation (1996) Application Notes: Liposome Characterization. Santa Barbara, CA.